International Clinical Trial: A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301)

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07296445) titled 'A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301)' on Dec. 16, 2025.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: SDK Therapeutics, Inc.

Condition: Acute Promyelocytic Leukemia (APL) Acute Promyelocytic Leukaemia Acute Promyelocytic Leukemia With PML-RARA Acute Promyelocytic Leukemia With t(15 17)(q24.1 q21.2) PML-RARA APL Acute Promyelocytic Leukemia Leukaemia Leukemia Ac...